Sorafenib Study: Dosing in Patients With Pulmonary Arterial Hypertension (PAH)
This study has been completed.
Sponsor:
University of Chicago
Collaborator:
Bayer
Information provided by (Responsible Party):
Mardi Gomberg-Maitland, University of Chicago
ClinicalTrials.gov Identifier:
NCT00452218
First received: March 26, 2007
Last updated: September 21, 2012
Last verified: September 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | May 2012 |
| Primary Completion Date: | May 2012 (Final data collection date for primary outcome measure) |